Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
6.6M
-
Shares change
-
+923K
-
Total reported value, excl. options
-
$27.7M
-
Value change
-
+$3.27M
-
Put/Call ratio
-
0.18
-
Number of buys
-
31
-
Number of sells
-
-20
-
Price
-
$4.20
Significant Holders of Niagen Bioscience, Inc. - COM NEW (NAGE) as of Q1 2018
71 filings reported holding NAGE - Niagen Bioscience, Inc. - COM NEW as of Q1 2018.
Niagen Bioscience, Inc. - COM NEW (NAGE) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.6M shares
.
Largest 10 shareholders include ICONIQ Capital, LLC (1.71M shares), VANGUARD GROUP INC (1.24M shares), Tieton Capital Management, LLC (561K shares), MILLENNIUM MANAGEMENT LLC (505K shares), GOLDMAN SACHS GROUP INC (229K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (218K shares), GEODE CAPITAL MANAGEMENT, LLC (175K shares), Invesco Ltd. (172K shares), BlueCrest Capital Management Ltd (125K shares), and UBS Group AG (121K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.